Beth Hoffman
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
Dr. Beth J.
Hoffman is an Independent Director at Biofrontera, Inc. and a President & Chief Executive Officer at Origami Therapeutics, Inc. She is on the Board of Directors at Biofrontera, Inc. She received her doctorate degree from The Johns Hopkins University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOFRONTERA, INC. -.--% | 04/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOFRONTERA INC. | Directeur/Membre du Conseil | 03/03/2015 |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Directeur Général | 01/01/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofrontera, Inc.
Biofrontera, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes dermatological drugs | Health Technology |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national